MAGNOLIA CAPITAL ADVISORS LLC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1803662 RIDGELAND, MS

Position in ACHV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$98,603

+$27,749 QoQ

Shares Held

15,100

-37.3% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#83

of 110 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MAGNOLIA CAPITAL ADVISORS LLC holds $1,324,366 across 4 Biotechnology names. ACHV ranks #4 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DMAC	DiaMedica Therapeutics Inc.	77,405	$544,931
2	VKTX	Viking Therapeutics, Inc.	12,115	$472,606
3	PGEN	Precigen, Inc.	36,531	$208,226
4	ACHV	Achieve Life Sciences, Inc. This page	15,100	$98,603

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$98,603	15,100	-37.3%	Shares	Sole	2026-08-14
2026-03-31	$70,854	24,100	+87.5%	Shares	Sole	2026-05-15
2025-12-31	$63,864	12,850	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.